Group 1 - The resignation of director Ni Wen is due to the company's governance structure adjustment, and he will continue to serve as the Chief Financial Officer [1] - The resignation will not affect the minimum number of board members or the normal operation of the board [1] - The company held a staff representative meeting on September 15, 2025, to elect Li Jing as the staff representative director for the fourth board [2] Group 2 - Li Jing's qualifications meet the legal and regulatory requirements for a director, and her appointment does not exceed the limit of management personnel on the board [2] - The company held its first temporary shareholders' meeting on September 15, 2025, to discuss various proposals, including the cancellation of the supervisory board [5][7] - All proposals at the shareholders' meeting were approved, including amendments to the company's articles of association and governance rules [7][8]
基蛋生物科技股份有限公司关于董事辞职暨选举职工代表董事的公告